Diabetes

Hormone may offer new approach to type 2 diabetes

Researchers at the Norwegian University of Science and Technology (NTNU) and Oxford University have found a hormone that may offer an effective treatment for type 2 diabetes.

Cardiology

CABG underused in diabetes with multivessel disease

(HealthDay)—About one-third of patients with diabetes mellitus and multivessel coronary artery disease presenting with non-ST-segment elevation myocardial infarction undergo coronary artery bypass graft (CABG) and more ...

Cardiology

Review finds CABG bests PCI in end-stage renal disease

(HealthDay)—For patients with end-stage renal disease (ESRD) referred for coronary revascularization, coronary artery bypass grafting (CABG) is associated with a small decrease in long-term mortality compared with percutaneous ...

page 30 from 40